WO2005023306A3 - Combination of medicaments comprising lansoprazole and domperidone - Google Patents

Combination of medicaments comprising lansoprazole and domperidone Download PDF

Info

Publication number
WO2005023306A3
WO2005023306A3 PCT/BR2004/000166 BR2004000166W WO2005023306A3 WO 2005023306 A3 WO2005023306 A3 WO 2005023306A3 BR 2004000166 W BR2004000166 W BR 2004000166W WO 2005023306 A3 WO2005023306 A3 WO 2005023306A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutically acceptable
domperidone
lansoprazole
medicaments
combination
Prior art date
Application number
PCT/BR2004/000166
Other languages
French (fr)
Other versions
WO2005023306A2 (en
Inventor
Negrao Alexandre Funari
Original Assignee
Medley S A Ind Farmaceutica
Negrao Alexandre Funari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medley S A Ind Farmaceutica, Negrao Alexandre Funari filed Critical Medley S A Ind Farmaceutica
Publication of WO2005023306A2 publication Critical patent/WO2005023306A2/en
Publication of WO2005023306A3 publication Critical patent/WO2005023306A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Abstract

The present invention is dealing about a combination of medicaments, medicinal association, medicament and medicament of facilitating presentation type, comprising in an individualized form yet combined at the same time: - one or more medicinal units containing the active principle lansoprazole, its derivatives or pharmaceutically acceptable salts; - one or more medicinal units containing the active principle domperidone, its derivatives and pharmaceutically acceptable salts; and at option other additives or drugs known by the man of the technique in vehicle or carrier also pharmaceutically acceptable.
PCT/BR2004/000166 2003-09-05 2004-09-03 Combination of medicaments comprising lansoprazole and domperidone WO2005023306A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR0303794-0A BR0303794A (en) 2003-09-05 2003-09-05 Medication, Medication Kit, Medication Set, Medication Association and Medication Presenting Facilitated Presentation
BRPI0303794-0 2003-09-05

Publications (2)

Publication Number Publication Date
WO2005023306A2 WO2005023306A2 (en) 2005-03-17
WO2005023306A3 true WO2005023306A3 (en) 2005-04-21

Family

ID=34230443

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2004/000166 WO2005023306A2 (en) 2003-09-05 2004-09-03 Combination of medicaments comprising lansoprazole and domperidone

Country Status (2)

Country Link
BR (1) BR0303794A (en)
WO (1) WO2005023306A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011136750A1 (en) * 2010-04-26 2011-11-03 Mahmut Bilgic Pharmaceutical compositions inducing synergistic effect

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089414A2 (en) * 2003-04-08 2004-10-21 Medley S.A. Indústria Farmacêutica Combinations of proton pump inhibitors or blockers with prokinetic agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089414A2 (en) * 2003-04-08 2004-10-21 Medley S.A. Indústria Farmacêutica Combinations of proton pump inhibitors or blockers with prokinetic agents

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ALI RIZA SOYLU ET AL: "COMBINED LANSOPRAZOLE IN CISAPRIDE THERAPY IMPROVES PULMONARY SYMPTOMS IN ASTHMATICS WITH GASTROESOPHAGEAL REFLUX", GASTROENTEROLOGY, SAUNDERS, PHILADELPHIA, PA,, US, vol. 120, no. 5, SUPPL 1, April 2001 (2001-04-01), pages A - 403, XP008002270, ISSN: 0016-5085 *
MONES J ET AL: "CRITERIA USED BY GENERAL PRACTIVIONERS IN PRESCRIBING PROKINETIC OR ANTISECRETORY DRUGS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA", REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, GARSI, MADRID,, ES, vol. 93, no. 5, 2001, pages 287 - 292, XP008037880, ISSN: 1130-0108 *
THJODLEIFSSON B: "TREATMENT OF ACID-RELATED DISEASES IN THE ELDERLY WITH EMPHASIS ON THE USE OF PROTON PUMP INHIBITORS", DRUGS AND AGING, ADIS INTERNATIONAL LTD, NZ, vol. 19, no. 12, 2002, pages 911 - 927, XP008037878, ISSN: 1170-229X *

Also Published As

Publication number Publication date
BR0303794A (en) 2005-04-12
WO2005023306A2 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
MXPA03007712A (en) Pharmaceutical salts.
WO2005082414A3 (en) Concomitant drugs of a sulfonamide and another therapeutic agent
BRPI0406911A (en) Pharmaceutical and / or cosmetic product
WO2008060964A3 (en) Unit dosage package and methods for administering weight loss medications
IL138767A0 (en) Anticancer compositions
WO2003082247A3 (en) Drug microparticles
WO2005065319A3 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2005117895A3 (en) Compositions comprising meloxicam
WO2004009445A3 (en) Packaging and dispensing of rapid dissolve dosage form
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
WO2005020906A3 (en) Intranasal opioid compositions
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2003077825A3 (en) Site specific delivery of co-administered drugs via inhalation
ATE287264T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
WO2005044187A3 (en) Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
WO2004098594A3 (en) Dosage form containing pantoprazole as active ingredient
WO2004034962A3 (en) Selective cytokine inhibitory drugs for treating myelodysplastic syndrome
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
WO2005110358A3 (en) Film-shaped estriol-containing medicament for oral administration
TN2010000008A1 (en) Oral pharmaceutical solutions containing telbivudine
WO2005023306A3 (en) Combination of medicaments comprising lansoprazole and domperidone
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase